SCHEMBL24283856

SCHEMBL24283856

Cc1ccc(CNC2=C(Br)C(=O)c3ccccc3C2=O)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 7/20 0.49
▸ KDM4E B2RXH2 6/20 0.49
▸ LMNA P02545 5/20 0.49
▸ ALDH1A1 P00352 5/20 0.49
▸ L3MBTL1 Q9Y468 5/20 0.49
▸ MAPK1 P28482 4/20 0.49
▸ APAF1 O14727 3/20 0.49
▸ TDP2 O95551 2/20 0.49
▸ CASP3 P42574 2/20 0.49
▸ SENP8 Q96LD8 2/20 0.49
▸ SENP7 Q9BQF6 2/20 0.49
▸ SENP6 Q9GZR1 2/20 0.49
▸ GAA P10253 2/20 0.49
▸ RAB9A P51151 6/20 0.48
▸ HTT P42858 5/20 0.48
▸ KMT2A Q03164 5/20 0.48
▸ MEN1 O00255 4/20 0.48
▸ NPC1 O15118 3/20 0.48
▸ MITF O75030 1/20 0.48
▸ POLB P06746 4/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22212590 0.82 MAPT (0.63) MAPTKDM4ELMNAALDH1A1L3MBTL1
SCHEMBL12352057 0.76 MAPT (0.76) MAPTKDM4ELMNAALDH1A1L3MBTL1
SCHEMBL18791129 0.73 MAOA (0.67) MAPTKDM4ELMNAALDH1A1L3MBTL1
SCHEMBL15700128 0.73 ALDH1A1 (0.60) MAPTKDM4ELMNAALDH1A1L3MBTL1
SCHEMBL30589283 0.72 RAB9A (0.54) MAPTKDM4ELMNAALDH1A1GAA
SCHEMBL18398708 0.72 RAB9A (0.54) MAPTKDM4ELMNAALDH1A1GAA
SCHEMBL21939350 0.71 MAPT (0.53) MAPTKDM4ELMNAALDH1A1L3MBTL1
SCHEMBL881115 0.71 MAPT (0.77) MAPTKDM4ELMNAALDH1A1L3MBTL1
SCHEMBL10696564 0.70 NSD2 (0.56) MAPTLMNAALDH1A1MAPK1HTT
SCHEMBL7913503 0.70 MAPT (0.61) MAPTKDM4ELMNAALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3324954-B1 AMINONAPTHOQUINONE COMPOUNDS AND PHARMACEUTICAL COMPOSITION FOR BLOCKING UBIQUITINATION-PROTEASOME SYSTEM IN DISEASES CALGENT BIOTECHNOLOGY CO LTD (TW) 2022-03-09 — — EP disclosed
Send feedback